NL7007861A - - Google Patents

Info

Publication number
NL7007861A
NL7007861A NL7007861A NL7007861A NL7007861A NL 7007861 A NL7007861 A NL 7007861A NL 7007861 A NL7007861 A NL 7007861A NL 7007861 A NL7007861 A NL 7007861A NL 7007861 A NL7007861 A NL 7007861A
Authority
NL
Netherlands
Application number
NL7007861A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7007861A publication Critical patent/NL7007861A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7007861A 1969-05-30 1970-05-29 NL7007861A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB27407/69A GB1263987A (en) 1969-05-30 1969-05-30 Phenethylamine derivatives

Publications (1)

Publication Number Publication Date
NL7007861A true NL7007861A (ja) 1970-12-02

Family

ID=10259075

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7007861A NL7007861A (ja) 1969-05-30 1970-05-29

Country Status (11)

Country Link
US (1) US3689524A (ja)
JP (2) JPS5330701B1 (ja)
BE (1) BE751190A (ja)
CA (1) CA960690A (ja)
CH (1) CH536815A (ja)
DK (1) DK130921B (ja)
FR (1) FR2051566B1 (ja)
GB (1) GB1263987A (ja)
NL (1) NL7007861A (ja)
SE (1) SE372934B (ja)
ZA (1) ZA703451B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081371A1 (en) * 1969-12-17 1971-12-03 Pfizer Beta-adrenergic blocking propanolamine - derivs

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038313A (en) * 1970-01-08 1977-07-26 Ciba-Geigy Corporation Cycloalkylureido phenoxy propanolamines
US3935259A (en) * 1970-01-08 1976-01-27 Ciba-Geigy Corporation New amines and processes for their manufacture
US4120978A (en) * 1970-01-08 1978-10-17 Ciba-Geigy Corporation Pharmaceutical composition for inhibiting and blocking cardioselective beta-receptors
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3976783A (en) * 1970-07-18 1976-08-24 Pfizer Inc. Method of stimulating the heart employing ureido substituted phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
US3972919A (en) * 1970-12-17 1976-08-03 Smithkline Corporation p-Hydroxymethylphenylglycine
US3862222A (en) * 1971-01-11 1975-01-21 Smithkline Corp {60 amino-4-benzyloxy-3-ureidoacetophenones
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament
US4024281A (en) * 1972-05-26 1977-05-17 Smithkline Corporation N,N-bis[2-(3-substituted-4-hydroxyphenyl)-ethyl or -2-hydroxyethyl]-polymethylenediamines
US4035420A (en) * 1972-07-06 1977-07-12 Aktiebolaget Hassle Substituted ureido alkylene phenoxy propanolamines
US4000197A (en) * 1973-07-23 1976-12-28 The University Of Iowa Research Foundation Asymmetric synthesis of phenylisopropylamines
NL7404732A (nl) * 1974-04-08 1975-10-10 Philips Nv Spasmolytice.
US4163060A (en) * 1974-04-08 1979-07-31 U.S. Philips Corporation Aralkylamino carboxylic acids and derivatives having spasmolytic activity
US4145363A (en) * 1975-02-05 1979-03-20 Yamanouchi Pharmaceutical Co., Ltd. 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives
DE3586123D1 (de) * 1984-08-15 1992-07-02 Schering Ag Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
US4629730A (en) * 1985-04-11 1986-12-16 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4642378A (en) * 1985-04-11 1987-02-10 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4847269A (en) * 1985-04-11 1989-07-11 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
BRPI9509411B8 (pt) 1994-10-21 2021-07-06 Nps Pharma Inc composto modulador de receptor de íon inorgânico e composição farmacêutica
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ES2201300T3 (es) * 1996-05-01 2004-03-16 Nps Pharmaceuticals, Inc. Compuestos activos frente a receptores de iones inorganicos.
GB201208775D0 (en) * 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081371A1 (en) * 1969-12-17 1971-12-03 Pfizer Beta-adrenergic blocking propanolamine - derivs

Also Published As

Publication number Publication date
DE2026402A1 (de) 1970-12-03
US3689524A (en) 1972-09-05
JPS5330701B1 (ja) 1978-08-29
FR2051566B1 (ja) 1974-02-22
GB1263987A (en) 1972-02-16
DK130921B (da) 1975-05-05
SE372934B (ja) 1975-01-20
JPS547782B1 (ja) 1979-04-10
CH536815A (de) 1973-05-15
ZA703451B (en) 1971-01-27
FR2051566A1 (ja) 1971-04-09
CA960690A (en) 1975-01-07
BE751190A (fr) 1970-11-30
DE2026402B2 (de) 1977-06-02
DK130921C (ja) 1975-10-06

Similar Documents

Publication Publication Date Title
AU2270770A (ja)
AU465452B2 (ja)
AU429630B2 (ja)
AU450150B2 (ja)
JPS5231858B1 (ja)
AU2355770A (ja)
AU442375B2 (ja)
AU470301B1 (ja)
AU427401B2 (ja)
AU428129B2 (ja)
AU414607B2 (ja)
AU442463B2 (ja)
AU442357B2 (ja)
AU442322B2 (ja)
AU442285B2 (ja)
AU470661B1 (ja)
AU438128B2 (ja)
AT308690B (ja)
AU442538B2 (ja)
AU428131B2 (ja)
AU442380B2 (ja)
AU428074B2 (ja)
AU442554B2 (ja)
AU410358B2 (ja)
AU417208B2 (ja)